Neonatal hypoglycaemia: Aetiologies

Seminars in Neonatology

Volumn 9, Issue 1, 2004, Pages 49-58

  De Lonlay, Pascale ^a   Giurgea, Irina ^a   Touati, Guy ^a   Saudubray, Jean Marie ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cortisol; Fatty acid disorder; Glucagon; Gluconeogenesis; Glucose transporter disorders; Growth hormone; Hyperinsulinism; Hypoglycaemia; Insulin like growth factor 1

Indexed keywords

GLUCAGON; GLUCOSE TRANSPORTER; GLYCOGEN; GROWTH HORMONE; HYDROCORTISONE; MANNOSE PHOSPHATE ISOMERASE; SOMATOMEDIN C;

DIET RESTRICTION; DISEASE CLASSIFICATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE DELETION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCOGEN STORAGE DISEASE; GLYCOSYLATION; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; INSULIN RELEASE; KETOGENESIS; NEWBORN HYPOGLYCEMIA; NORMAL VALUE; RESPIRATORY CHAIN; REVIEW;

EID: 1642471679     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2003.08.002     Document Type: Review

References (48)

1. Volpe JJ. Hypoglycemia and brain injury. In: Volpe JJ, editor. Neurology of the newborn. Philadelphia: WB Saunders Co., 1995;467-89.
2. Cornblath M, Schwartz R, Aynsley-Green A et al. Hypoglycemia in infancy: the need for a rational definition. Pediatrics 1990;85:834-7.
3. Pagliara AS, Karl IE, Haymond M et al. Hypoglycemia in infancy and childhood. Part I. J Pediatr 1973;82:365-79.
4. Van den Berghe G. Role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J Inherit Metab Dis 1991;14:407-35.
5. De Lonlay-Debeney P, Poggi-Travert F, Fournet JC et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999;340:1169-75.
6. Leibowitz G, Glaser B, Higazi AA et al. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent B-cell dysfunction at long-term follow J Clin Endocrinol Metab 1995;80:386-92.
7. +ATP channels in persistent hyperinsulinemic hypoglycaemia of infancy. Nat Med 1996;2:1344-7.
8. Lindley KJ, Dunne MJ, Kane C et al. Ionic control of B-cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child 1996;74:373-8.
9. Sempoux C, Guiot Y, Lefevre A et al. Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 1998;83:1455-61.
10. Rahier J, Fälts K, Münterfering H et al. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 1984;26:282-9.
11. Rahier J, Sempoux C, Fournet JC et al. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology 1998;32:15-9.
12. Brunelle F, Negre V, Barth MO et al. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989;19:100-3.
13. Dubois J, Brunelle F, Touati G et al. Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25:512-6.
14. De Lonlay P, Fournet JC, Rahier J et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997;100:802-7.
15. Verkarre V, Fournet JC, de Lonlay P et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998;102:1286-91.
16. Thomas PM, Cote GJ, Wohllk N et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-9.
17. Nestorowicz A, Wilson BA, Schoor KP et al. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996;5:1813-22.
18. Nestorowicz A, Inagaki N, Gonoit T et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 1997;46:1743-8.
19. Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996;5:1809-12.
20. Glaser B, Kesavan P, Heyman M et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998;338:226-30.
21. Kukuvitis A, Deal C, Arbour L et al. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy, not linked to the sulfonylurea receptor locus. J Clin Endocrinol Metab 1997;82:1192-4.
22. Stanley CA, Lieu YK, Hsu BY et al. Hyperinsulinemia and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998;338:1352-7.
23. Zammarchi E, Filippi L, Novembre E et al. Biochemical evaluation of a patient with a familial form of leucine-sensitive hypoglycemia and concomitant hyperammonemia. Metabolism 1996;45:957-60.
24. Clayton PT, Eaton S, Aynsley-Green A et al. Hyperinsulinism in short-chain l-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 2001;108:457-65.
25. Dershewitz R, Vestal B, Maclaren N et al. Malicious insulin administration resulting in transient hepatomegaly and hypoglycemia. Am J Dis Child 1976;130:998-9.
26. Gregersen N, Lauritzen R, Rasmussen K. Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria. Clin Chim Acta 1976;70:417-25.
27. Saudubray JM, Martin D, De Lonlay P et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999;22:488-502.
28. Vianey-Saban C, Divry P, Gregersen N et al. The inborn errors of mitochondrial fatty acid oxidation. J Inherit Metab Dis 1987;10(Suppl 1):159-98.
29. Millington DS, Terada N, Chace DH et al. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. In: Coates PM, Tanaka K, editors. New developments in fatty acid oxidation. Progress in clinical and biological research. New York: John Wiley-Liss, 1992;339-54.
30. Nada M, Rhead W, Sprecher H et al. Evidence for intermediate channeling of mitochondrial B-oxidation. J Biol Chem 1995;270:530-5.
31. Gibson KM, Breuer J, Nyhan WL. 3-Hydroxy-3-methyglutaryl-CoA lyase deficiency: a review of 18 reported patients. Eur J Pediatr 1988;148:180-6.
32. Thompson GN, Hsu BY, Pitt JJ et al. Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med 1997;337:1203-7.
33. Leonard JV, Middleton B, Seakins JW. Acetoacetyl-CoA thiolase deficiency presenting as ketotic hypoglycemia. Pediatr Res 1987;21:211-3.
34. Niezen-Koning KE, Wanders RJ, Ruiter JP et al. Succinyl-CoA: acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature. Eur J Pediatr 1997;156:870-3.
35. Saudubray JM, Specola N, Middleton B et al. Hyperketotic states due to inherited defects of ketolysis. Enzyme 1987;38:80-90.
36. Lei KJ, Shelly LL, Pan CJ et al. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type la. Science 1993;262:580-3.
37. Gitzelmann R, Spycher MA, Feil G et al. Liver glycogen synthase deficiency: a rarely diagnosed entity. Eur J Pediatr 1996;155:561-7.
38. Ruderman NB, Aoki TT, Cahill GF. Gluconeogenesis and its disorders in man. In: Hanson RW, Mehlman MA, editors. Gluconeogenesis, its regulation in mammalian species. New York: John Wiley and Sons, 1976;515-32.
39. De Vivo DC, Trifiletti RR, Jacobson RI et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991;325:703-9.
40. Santer R, Schneppenheim R, Dombrowski A et al. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 1997;17:324-6.
41. Seidner G, Garcia Alvarez M, Yeh JI et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998;18:188-91.
42. Jaquet D, Touati G, Rigal O et al. Exploration of glucose homeostasis during fasting in growth-hormone-deficient children. Acta Paediatr 1998;87:505-10.
43. Lovinger RD, Kaplan SL, Grumbach MM. Congenital hypopituitarism associated with neonatal hypoglycemia and microphallus: four cases secondary to hypothalamic hormone deficiencies. J Pediatr 1975;87:1171-81.
44. Laron Z, Blum W, Chatelain P et al. Classification of growth hormone insensitivity syndrome. J Pediatr 1993;122:141.
45. Laron Z, Avitzur Y, Klinger B. Carbohydrate metabolism in primary GH resistance (Laron syndrome) before and during IGF-1 treatment. Metabolism 1995;44(Suppl 4):486-90.
46. Laron Z. Short stature due to genetic defects affecting growth hormone activity. N Engl J Med 1996;334:463-5.
47. Froesch ER, Hussain M. The metabolic effects of insulin-like growth factor I with special reference to diabetes. Acta Paediatr 1994; 399(Suppl)):165-70.
48. Vidnes J, Oyasaeter S. Glucagon deficiency causing severe neonatal hypoglycemia in a patient with a normal insulin secretion. Pediatr Res 1977;11:943-9.